(Q53028092)

10 May 2018

editorial

0 references

review article

1 reference

title

Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? (English)

1 reference

10 May 2018

1 reference

1 reference

Jörg Dötsch

1

1 reference

10 May 2018

Dirk E Müller-Wiefel

series ordinal

2

1 reference

10 May 2018

Markus J Kemper

series ordinal

3

1 reference

10 May 2018

publication date

26 September 2007

1 reference

10 May 2018

published in

Pediatric Nephrology

1 reference

10 May 2018

volume

23

1 reference

10 May 2018

issue

1

1 reference

10 May 2018

page(s)

3-7

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1007/s00467-007-0596-x

exact match

0 references

cites work

Management of minimal lesion glomerulonephritis: evidence-based recommendations

1 reference

12 December 2020

A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis

1 reference

12 December 2020

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

1 reference

12 December 2020

Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?

1 reference

12 December 2020

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

1 reference

12 December 2020

Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

1 reference

12 December 2020

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

12 December 2020

Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab

1 reference

12 December 2020

Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Rituximab therapy for steroid-dependent minimal change nephrotic syndrome

1 reference

12 December 2020

Rituximab for idiopathic membranous nephropathy

1 reference

12 December 2020

A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties

1 reference

12 December 2020

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

1 reference

12 December 2020

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

12 December 2020

Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?

1 reference

12 December 2020

Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome

1 reference

12 December 2020

Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

1 reference

12 December 2020

Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function

1 reference

12 December 2020

Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab

1 reference

12 December 2020

Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.

1 reference

12 December 2020

Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse

1 reference

12 December 2020

Tolerability and safety of rituximab (MabThera).

1 reference

12 December 2020

Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome

1 reference

12 December 2020

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

12 December 2020

Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations

1 reference

12 December 2020

Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A?

1 reference

12 December 2020

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

12 December 2020

10.1007/S00467-007-0596-X

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018